| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.29B | +10.4% |
| Cost of Revenue | $984.2M | +7.7% |
| Gross Profit | $304.5M | +20.2% |
| R&D Expense | $9.5M | — |
| SG&A Expense | $147.1M | +20.6% |
| Operating Income | $85.3M | +26.4% |
| Pre-tax Income | $95.4M | +14.7% |
| Income Tax | $36.9M | +27.9% |
| Net Income | $58.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $112.2M | -30.9% |
| Accounts Receivable | $220.3M | -6.4% |
| Current Assets | $551.8M | +16.7% |
| Total Assets | $742.4M | +22.3% |
| Current Liabilities | $202.4M | +20.0% |
| Total Liabilities | $226.4M | +22.3% |
| Stockholders' Equity | $516.0M | +22.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $210.2M | +17.4% |
| Capital Expenditures | $18.4M | +240.6% |
| Investing Cash Flow | -$159.0M | -181.2% |
| Financing Cash Flow | -$99.4M | +67.9% |
| Free Cash Flow | $191.8M | +10.4% |
| +7.7% |
| EPS (Basic) | $0.68 | +15.3% |
| EPS (Diluted) | $0.65 | +14.0% |